Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies', we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies', only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr Maxime Taquet, Academic Clinical Fellow (ACF), and colleagues have found ‘evidence for substantial neurological and psychiatric morbidity in the 6 months after COVID-19 infection’.

The study, which is the largest of its kind so far, was published in The Lancet Psychiatry. It was led by Paul Harrison, Professor of Psychiatry, University of Oxford.

Dr Taquet, who conducted the analyses, is a clinical academic trainee on the NIHR Integrated Clinical Academic Pathway. Before becoming an ACF, he was an Academic Foundation trainee, also with OUCAGS.


Further reading:

Dr Taquet’s career trajectory before becoming an Academic Clinical Fellow

The clinical academic pathway on OUCAGS’ website

The open-access article on The Lancet Psychiatry’s website